Revitalist Lifestyle and Wellness Ltd.
Revitalist Lifestyle and Wellness Ltd. RVLWF Peers
See (RVLWF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RVLWF | $0.04 | +97.97% | 38.9B | -0.30 | -$0.13 | N/A |
| FSNUY | $12.64 | -0.32% | 113.9B | 23.85 | $0.53 | +1.90% |
| FSNUF | $50.29 | +33.29% | 28.3B | 23.72 | $2.12 | +1.84% |
| FMCQF | $58.68 | N/A | 17.2B | 24.55 | $2.39 | +2.44% |
| BDUUY | $32.33 | N/A | 12.8B | 28.36 | $1.14 | +2.79% |
| BDULF | $0.71 | N/A | 11.3B | 23.67 | $0.03 | +3.13% |
| JDHIY | $3.25 | +100.00% | 10.4B | 18.06 | $0.18 | N/A |
| JDHIF | $3.23 | N/A | 10.3B | 26.92 | $0.12 | N/A |
| IHHHF | $1.10 | -7.56% | 9.7B | 15.71 | $0.07 | +1.25% |
| BDUUF | $0.60 | N/A | 9.5B | 20.00 | $0.03 | +3.70% |
Stock Comparison
RVLWF vs FSNUY Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, FSNUY has a market cap of 113.9B. Regarding current trading prices, RVLWF is priced at $0.04, while FSNUY trades at $12.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas FSNUY's P/E ratio is 23.85. In terms of profitability, RVLWF's ROE is +3.95%, compared to FSNUY's ROE of +0.02%. Regarding short-term risk, RVLWF is less volatile compared to FSNUY. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs FSNUF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, FSNUF has a market cap of 28.3B. Regarding current trading prices, RVLWF is priced at $0.04, while FSNUF trades at $50.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas FSNUF's P/E ratio is 23.72. In terms of profitability, RVLWF's ROE is +3.95%, compared to FSNUF's ROE of +0.02%. Regarding short-term risk, RVLWF is less volatile compared to FSNUF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs FMCQF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, FMCQF has a market cap of 17.2B. Regarding current trading prices, RVLWF is priced at $0.04, while FMCQF trades at $58.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas FMCQF's P/E ratio is 24.55. In terms of profitability, RVLWF's ROE is +3.95%, compared to FMCQF's ROE of +0.04%. Regarding short-term risk, RVLWF is less volatile compared to FMCQF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs BDUUY Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, BDUUY has a market cap of 12.8B. Regarding current trading prices, RVLWF is priced at $0.04, while BDUUY trades at $32.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas BDUUY's P/E ratio is 28.36. In terms of profitability, RVLWF's ROE is +3.95%, compared to BDUUY's ROE of +0.16%. Regarding short-term risk, RVLWF is less volatile compared to BDUUY. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs BDULF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, BDULF has a market cap of 11.3B. Regarding current trading prices, RVLWF is priced at $0.04, while BDULF trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas BDULF's P/E ratio is 23.67. In terms of profitability, RVLWF's ROE is +3.95%, compared to BDULF's ROE of +0.16%. Regarding short-term risk, RVLWF is less volatile compared to BDULF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs JDHIY Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, JDHIY has a market cap of 10.4B. Regarding current trading prices, RVLWF is priced at $0.04, while JDHIY trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas JDHIY's P/E ratio is 18.06. In terms of profitability, RVLWF's ROE is +3.95%, compared to JDHIY's ROE of +0.05%. Regarding short-term risk, RVLWF and JDHIY have similar daily volatility (0.00).
RVLWF vs JDHIF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, JDHIF has a market cap of 10.3B. Regarding current trading prices, RVLWF is priced at $0.04, while JDHIF trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas JDHIF's P/E ratio is 26.92. In terms of profitability, RVLWF's ROE is +3.95%, compared to JDHIF's ROE of +0.05%. Regarding short-term risk, RVLWF is less volatile compared to JDHIF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs IHHHF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, IHHHF has a market cap of 9.7B. Regarding current trading prices, RVLWF is priced at $0.04, while IHHHF trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas IHHHF's P/E ratio is 15.71. In terms of profitability, RVLWF's ROE is +3.95%, compared to IHHHF's ROE of +0.09%. Regarding short-term risk, RVLWF is less volatile compared to IHHHF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs BDUUF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, BDUUF has a market cap of 9.5B. Regarding current trading prices, RVLWF is priced at $0.04, while BDUUF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas BDUUF's P/E ratio is 20.00. In terms of profitability, RVLWF's ROE is +3.95%, compared to BDUUF's ROE of +0.16%. Regarding short-term risk, RVLWF is less volatile compared to BDUUF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs RMSYF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, RMSYF has a market cap of 5.5B. Regarding current trading prices, RVLWF is priced at $0.04, while RMSYF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas RMSYF's P/E ratio is 480.00. In terms of profitability, RVLWF's ROE is +3.95%, compared to RMSYF's ROE of +0.18%. Regarding short-term risk, RVLWF and RMSYF have similar daily volatility (0.00).
RVLWF vs BUGDF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, BUGDF has a market cap of 5B. Regarding current trading prices, RVLWF is priced at $0.04, while BUGDF trades at $6.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas BUGDF's P/E ratio is 24.27. In terms of profitability, RVLWF's ROE is +3.95%, compared to BUGDF's ROE of +0.28%. Regarding short-term risk, RVLWF is less volatile compared to BUGDF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs RMYHY Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, RMYHY has a market cap of 4.9B. Regarding current trading prices, RVLWF is priced at $0.04, while RMYHY trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas RMYHY's P/E ratio is 533.00. In terms of profitability, RVLWF's ROE is +3.95%, compared to RMYHY's ROE of +0.18%. Regarding short-term risk, RVLWF is less volatile compared to RMYHY. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs ANHGY Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, ANHGY has a market cap of 4B. Regarding current trading prices, RVLWF is priced at $0.04, while ANHGY trades at $5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas ANHGY's P/E ratio is 23.87. In terms of profitability, RVLWF's ROE is +3.95%, compared to ANHGY's ROE of N/A. Regarding short-term risk, RVLWF and ANHGY have similar daily volatility (0.00).
RVLWF vs BUHPF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, BUHPF has a market cap of 3.3B. Regarding current trading prices, RVLWF is priced at $0.04, while BUHPF trades at $4.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas BUHPF's P/E ratio is 17.96. In terms of profitability, RVLWF's ROE is +3.95%, compared to BUHPF's ROE of +0.28%. Regarding short-term risk, RVLWF is less volatile compared to BUHPF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs MCVEF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, MCVEF has a market cap of 3B. Regarding current trading prices, RVLWF is priced at $0.04, while MCVEF trades at $19.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas MCVEF's P/E ratio is 86.22. In terms of profitability, RVLWF's ROE is +3.95%, compared to MCVEF's ROE of +0.06%. Regarding short-term risk, RVLWF is less volatile compared to MCVEF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs ORPEF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, ORPEF has a market cap of 2.3B. Regarding current trading prices, RVLWF is priced at $0.04, while ORPEF trades at $14.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas ORPEF's P/E ratio is 0.03. In terms of profitability, RVLWF's ROE is +3.95%, compared to ORPEF's ROE of +0.91%. Regarding short-term risk, RVLWF is less volatile compared to ORPEF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs MCVEY Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, MCVEY has a market cap of 2.2B. Regarding current trading prices, RVLWF is priced at $0.04, while MCVEY trades at $16.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas MCVEY's P/E ratio is 40.37. In terms of profitability, RVLWF's ROE is +3.95%, compared to MCVEY's ROE of +0.06%. Regarding short-term risk, RVLWF is less volatile compared to MCVEY. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs TTALF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, TTALF has a market cap of 1.6B. Regarding current trading prices, RVLWF is priced at $0.04, while TTALF trades at $12.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas TTALF's P/E ratio is 19.33. In terms of profitability, RVLWF's ROE is +3.95%, compared to TTALF's ROE of +0.15%. Regarding short-term risk, RVLWF and TTALF have similar daily volatility (0.00).
RVLWF vs RYHTY Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, RYHTY has a market cap of 1.5B. Regarding current trading prices, RVLWF is priced at $0.04, while RYHTY trades at $7.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas RYHTY's P/E ratio is -3.97. In terms of profitability, RVLWF's ROE is +3.95%, compared to RYHTY's ROE of +0.00%. Regarding short-term risk, RVLWF and RYHTY have similar daily volatility (0.00).
RVLWF vs LWSCF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, LWSCF has a market cap of 1.3B. Regarding current trading prices, RVLWF is priced at $0.04, while LWSCF trades at $13.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas LWSCF's P/E ratio is 45.60. In terms of profitability, RVLWF's ROE is +3.95%, compared to LWSCF's ROE of +0.07%. Regarding short-term risk, RVLWF is less volatile compared to LWSCF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs RHCGF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, RHCGF has a market cap of 1.2B. Regarding current trading prices, RVLWF is priced at $0.04, while RHCGF trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas RHCGF's P/E ratio is -3.27. In terms of profitability, RVLWF's ROE is +3.95%, compared to RHCGF's ROE of -0.02%. Regarding short-term risk, RVLWF is less volatile compared to RHCGF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs LTGHY Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, LTGHY has a market cap of 1.2B. Regarding current trading prices, RVLWF is priced at $0.04, while LTGHY trades at $3.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas LTGHY's P/E ratio is -23.71. In terms of profitability, RVLWF's ROE is +3.95%, compared to LTGHY's ROE of +0.40%. Regarding short-term risk, RVLWF is less volatile compared to LTGHY. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs LTGHF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, LTGHF has a market cap of 1.2B. Regarding current trading prices, RVLWF is priced at $0.04, while LTGHF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas LTGHF's P/E ratio is 11.70. In terms of profitability, RVLWF's ROE is +3.95%, compared to LTGHF's ROE of +0.29%. Regarding short-term risk, RVLWF is less volatile compared to LTGHF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs RAFLF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, RAFLF has a market cap of 1.1B. Regarding current trading prices, RVLWF is priced at $0.04, while RAFLF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas RAFLF's P/E ratio is 20.00. In terms of profitability, RVLWF's ROE is +3.95%, compared to RAFLF's ROE of +0.04%. Regarding short-term risk, RVLWF is less volatile compared to RAFLF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs RHKJF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, RHKJF has a market cap of 1B. Regarding current trading prices, RVLWF is priced at $0.04, while RHKJF trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas RHKJF's P/E ratio is 21.55. In terms of profitability, RVLWF's ROE is +3.95%, compared to RHKJF's ROE of +0.03%. Regarding short-term risk, RVLWF is less volatile compared to RHKJF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs RKAGY Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, RKAGY has a market cap of 1B. Regarding current trading prices, RVLWF is priced at $0.04, while RKAGY trades at $7.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas RKAGY's P/E ratio is 22.50. In terms of profitability, RVLWF's ROE is +3.95%, compared to RKAGY's ROE of +0.03%. Regarding short-term risk, RVLWF and RKAGY have similar daily volatility (0.00).
RVLWF vs NWKHY Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, NWKHY has a market cap of 1B. Regarding current trading prices, RVLWF is priced at $0.04, while NWKHY trades at $7.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas NWKHY's P/E ratio is 11.64. In terms of profitability, RVLWF's ROE is +3.95%, compared to NWKHY's ROE of +0.13%. Regarding short-term risk, RVLWF and NWKHY have similar daily volatility (0.00).
RVLWF vs EXETF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, EXETF has a market cap of 877.2M. Regarding current trading prices, RVLWF is priced at $0.04, while EXETF trades at $10.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas EXETF's P/E ratio is 16.35. In terms of profitability, RVLWF's ROE is +3.95%, compared to EXETF's ROE of +0.66%. Regarding short-term risk, RVLWF is less volatile compared to EXETF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs JXFGF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, JXFGF has a market cap of 755.6M. Regarding current trading prices, RVLWF is priced at $0.04, while JXFGF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas JXFGF's P/E ratio is 14.00. In terms of profitability, RVLWF's ROE is +3.95%, compared to JXFGF's ROE of +0.03%. Regarding short-term risk, RVLWF is less volatile compared to JXFGF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs WHTCF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, WHTCF has a market cap of 741.6M. Regarding current trading prices, RVLWF is priced at $0.04, while WHTCF trades at $2.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas WHTCF's P/E ratio is -36.63. In terms of profitability, RVLWF's ROE is +3.95%, compared to WHTCF's ROE of -0.03%. Regarding short-term risk, RVLWF and WHTCF have similar daily volatility (0.00).
RVLWF vs KDGTF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, KDGTF has a market cap of 675.1M. Regarding current trading prices, RVLWF is priced at $0.04, while KDGTF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas KDGTF's P/E ratio is -1.67. In terms of profitability, RVLWF's ROE is +3.95%, compared to KDGTF's ROE of N/A. Regarding short-term risk, RVLWF and KDGTF have similar daily volatility (0.00).
RVLWF vs WFHG Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, WFHG has a market cap of 471.2M. Regarding current trading prices, RVLWF is priced at $0.04, while WFHG trades at $7.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas WFHG's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to WFHG's ROE of +0.22%. Regarding short-term risk, RVLWF is less volatile compared to WFHG. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs ORRRY Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, ORRRY has a market cap of 371.5M. Regarding current trading prices, RVLWF is priced at $0.04, while ORRRY trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas ORRRY's P/E ratio is -0.33. In terms of profitability, RVLWF's ROE is +3.95%, compared to ORRRY's ROE of +0.91%. Regarding short-term risk, RVLWF and ORRRY have similar daily volatility (0.00).
RVLWF vs BTMDW Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, BTMDW has a market cap of 292.9M. Regarding current trading prices, RVLWF is priced at $0.04, while BTMDW trades at $1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas BTMDW's P/E ratio is 0.05. In terms of profitability, RVLWF's ROE is +3.95%, compared to BTMDW's ROE of -0.19%. Regarding short-term risk, RVLWF is less volatile compared to BTMDW. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs EVGRF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, EVGRF has a market cap of 234.9M. Regarding current trading prices, RVLWF is priced at $0.04, while EVGRF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas EVGRF's P/E ratio is -0.05. In terms of profitability, RVLWF's ROE is +3.95%, compared to EVGRF's ROE of +0.67%. Regarding short-term risk, RVLWF is less volatile compared to EVGRF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs MFCSF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, MFCSF has a market cap of 217.8M. Regarding current trading prices, RVLWF is priced at $0.04, while MFCSF trades at $11.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas MFCSF's P/E ratio is 7.36. In terms of profitability, RVLWF's ROE is +3.95%, compared to MFCSF's ROE of +0.84%. Regarding short-term risk, RVLWF is less volatile compared to MFCSF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs MKLNF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, MKLNF has a market cap of 217.6M. Regarding current trading prices, RVLWF is priced at $0.04, while MKLNF trades at $11.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas MKLNF's P/E ratio is 19.23. In terms of profitability, RVLWF's ROE is +3.95%, compared to MKLNF's ROE of +0.15%. Regarding short-term risk, RVLWF and MKLNF have similar daily volatility (0.00).
RVLWF vs CHHHF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, CHHHF has a market cap of 124.1M. Regarding current trading prices, RVLWF is priced at $0.04, while CHHHF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas CHHHF's P/E ratio is -49.25. In terms of profitability, RVLWF's ROE is +3.95%, compared to CHHHF's ROE of -0.05%. Regarding short-term risk, RVLWF and CHHHF have similar daily volatility (0.00).
RVLWF vs VTIAF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, VTIAF has a market cap of 82.8M. Regarding current trading prices, RVLWF is priced at $0.04, while VTIAF trades at $4.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas VTIAF's P/E ratio is -5.94. In terms of profitability, RVLWF's ROE is +3.95%, compared to VTIAF's ROE of +0.11%. Regarding short-term risk, RVLWF is less volatile compared to VTIAF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs MCIOF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, MCIOF has a market cap of 54M. Regarding current trading prices, RVLWF is priced at $0.04, while MCIOF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas MCIOF's P/E ratio is -1.22. In terms of profitability, RVLWF's ROE is +3.95%, compared to MCIOF's ROE of N/A. Regarding short-term risk, RVLWF and MCIOF have similar daily volatility (0.00).
RVLWF vs ASSF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, ASSF has a market cap of 45.3M. Regarding current trading prices, RVLWF is priced at $0.04, while ASSF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas ASSF's P/E ratio is -33.33. In terms of profitability, RVLWF's ROE is +3.95%, compared to ASSF's ROE of -6.63%. Regarding short-term risk, RVLWF and ASSF have similar daily volatility (0.00).
RVLWF vs KONEF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, KONEF has a market cap of 44.3M. Regarding current trading prices, RVLWF is priced at $0.04, while KONEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas KONEF's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to KONEF's ROE of -6.56%. Regarding short-term risk, RVLWF is less volatile compared to KONEF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs USNU Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, USNU has a market cap of 24.2M. Regarding current trading prices, RVLWF is priced at $0.04, while USNU trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas USNU's P/E ratio is -9.42. In terms of profitability, RVLWF's ROE is +3.95%, compared to USNU's ROE of -0.62%. Regarding short-term risk, RVLWF is less volatile compared to USNU. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs HQDA Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, HQDA has a market cap of 18.6M. Regarding current trading prices, RVLWF is priced at $0.04, while HQDA trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas HQDA's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to HQDA's ROE of +0.00%. Regarding short-term risk, RVLWF and HQDA have similar daily volatility (0.00).
RVLWF vs NVLPF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, NVLPF has a market cap of 18.1M. Regarding current trading prices, RVLWF is priced at $0.04, while NVLPF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas NVLPF's P/E ratio is 20.70. In terms of profitability, RVLWF's ROE is +3.95%, compared to NVLPF's ROE of +0.08%. Regarding short-term risk, RVLWF and NVLPF have similar daily volatility (0.00).
RVLWF vs FPCG Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, FPCG has a market cap of 10.3M. Regarding current trading prices, RVLWF is priced at $0.04, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas FPCG's P/E ratio is 0.09. In terms of profitability, RVLWF's ROE is +3.95%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, RVLWF and FPCG have similar daily volatility (0.00).
RVLWF vs XCRT Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, XCRT has a market cap of 8.1M. Regarding current trading prices, RVLWF is priced at $0.04, while XCRT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas XCRT's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to XCRT's ROE of +2.48%. Regarding short-term risk, RVLWF is less volatile compared to XCRT. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs NUMIF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, NUMIF has a market cap of 7M. Regarding current trading prices, RVLWF is priced at $0.04, while NUMIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas NUMIF's P/E ratio is -0.36. In terms of profitability, RVLWF's ROE is +3.95%, compared to NUMIF's ROE of -1.95%. Regarding short-term risk, RVLWF is less volatile compared to NUMIF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs BICX Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, BICX has a market cap of 6.1M. Regarding current trading prices, RVLWF is priced at $0.04, while BICX trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas BICX's P/E ratio is -0.88. In terms of profitability, RVLWF's ROE is +3.95%, compared to BICX's ROE of +0.40%. Regarding short-term risk, RVLWF is less volatile compared to BICX. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs HLYK Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, HLYK has a market cap of 5.6M. Regarding current trading prices, RVLWF is priced at $0.04, while HLYK trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas HLYK's P/E ratio is -1.00. In terms of profitability, RVLWF's ROE is +3.95%, compared to HLYK's ROE of +2.41%. Regarding short-term risk, RVLWF is less volatile compared to HLYK. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs RHEP Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, RHEP has a market cap of 4.8M. Regarding current trading prices, RVLWF is priced at $0.04, while RHEP trades at $2.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas RHEP's P/E ratio is -1.06. In terms of profitability, RVLWF's ROE is +3.95%, compared to RHEP's ROE of +1.29%. Regarding short-term risk, RVLWF is less volatile compared to RHEP. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs VLXC Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, VLXC has a market cap of 4.8M. Regarding current trading prices, RVLWF is priced at $0.04, while VLXC trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas VLXC's P/E ratio is -6.70. In terms of profitability, RVLWF's ROE is +3.95%, compared to VLXC's ROE of +0.68%. Regarding short-term risk, RVLWF is less volatile compared to VLXC. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs GBCS Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, GBCS has a market cap of 4.6M. Regarding current trading prices, RVLWF is priced at $0.04, while GBCS trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas GBCS's P/E ratio is -2.22. In terms of profitability, RVLWF's ROE is +3.95%, compared to GBCS's ROE of +0.56%. Regarding short-term risk, RVLWF is less volatile compared to GBCS. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs GRST Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, GRST has a market cap of 2.7M. Regarding current trading prices, RVLWF is priced at $0.04, while GRST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas GRST's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to GRST's ROE of +0.30%. Regarding short-term risk, RVLWF is less volatile compared to GRST. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs EPWCF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, EPWCF has a market cap of 2.5M. Regarding current trading prices, RVLWF is priced at $0.04, while EPWCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas EPWCF's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to EPWCF's ROE of +0.00%. Regarding short-term risk, RVLWF is less volatile compared to EPWCF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs JRSS Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, JRSS has a market cap of 1.9M. Regarding current trading prices, RVLWF is priced at $0.04, while JRSS trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas JRSS's P/E ratio is -0.37. In terms of profitability, RVLWF's ROE is +3.95%, compared to JRSS's ROE of +2.63%. Regarding short-term risk, RVLWF and JRSS have similar daily volatility (0.00).
RVLWF vs TOKIF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, TOKIF has a market cap of 1.8M. Regarding current trading prices, RVLWF is priced at $0.04, while TOKIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas TOKIF's P/E ratio is -0.01. In terms of profitability, RVLWF's ROE is +3.95%, compared to TOKIF's ROE of -0.83%. Regarding short-term risk, RVLWF is less volatile compared to TOKIF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs SMAS Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, SMAS has a market cap of 1.5M. Regarding current trading prices, RVLWF is priced at $0.04, while SMAS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas SMAS's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to SMAS's ROE of N/A. Regarding short-term risk, RVLWF is less volatile compared to SMAS. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs MDGP Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, MDGP has a market cap of 1.5M. Regarding current trading prices, RVLWF is priced at $0.04, while MDGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas MDGP's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to MDGP's ROE of -2.19%. Regarding short-term risk, RVLWF and MDGP have similar daily volatility (0.00).
RVLWF vs NOVC Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, NOVC has a market cap of 1.2M. Regarding current trading prices, RVLWF is priced at $0.04, while NOVC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas NOVC's P/E ratio is -0.20. In terms of profitability, RVLWF's ROE is +3.95%, compared to NOVC's ROE of +0.12%. Regarding short-term risk, RVLWF and NOVC have similar daily volatility (0.00).
RVLWF vs PHMB Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, PHMB has a market cap of 1.1M. Regarding current trading prices, RVLWF is priced at $0.04, while PHMB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas PHMB's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to PHMB's ROE of N/A. Regarding short-term risk, RVLWF is less volatile compared to PHMB. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs GNOW Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, GNOW has a market cap of 859.7K. Regarding current trading prices, RVLWF is priced at $0.04, while GNOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas GNOW's P/E ratio is -0.01. In terms of profitability, RVLWF's ROE is +3.95%, compared to GNOW's ROE of +0.00%. Regarding short-term risk, RVLWF and GNOW have similar daily volatility (0.00).
RVLWF vs NXGT Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, NXGT has a market cap of 480.8K. Regarding current trading prices, RVLWF is priced at $0.04, while NXGT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas NXGT's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to NXGT's ROE of +0.09%. Regarding short-term risk, RVLWF and NXGT have similar daily volatility (0.00).
RVLWF vs ARPC Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, ARPC has a market cap of 336.6K. Regarding current trading prices, RVLWF is priced at $0.04, while ARPC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas ARPC's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to ARPC's ROE of -0.56%. Regarding short-term risk, RVLWF is less volatile compared to ARPC. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs JNHMF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, JNHMF has a market cap of 335.9K. Regarding current trading prices, RVLWF is priced at $0.04, while JNHMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas JNHMF's P/E ratio is -0.07. In terms of profitability, RVLWF's ROE is +3.95%, compared to JNHMF's ROE of +0.81%. Regarding short-term risk, RVLWF is less volatile compared to JNHMF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs SETO Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, SETO has a market cap of 299.4K. Regarding current trading prices, RVLWF is priced at $0.04, while SETO trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas SETO's P/E ratio is -2.40. In terms of profitability, RVLWF's ROE is +3.95%, compared to SETO's ROE of +0.00%. Regarding short-term risk, RVLWF and SETO have similar daily volatility (0.00).
RVLWF vs FCHS Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, FCHS has a market cap of 283.4K. Regarding current trading prices, RVLWF is priced at $0.04, while FCHS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas FCHS's P/E ratio is -0.07. In terms of profitability, RVLWF's ROE is +3.95%, compared to FCHS's ROE of +0.12%. Regarding short-term risk, RVLWF is less volatile compared to FCHS. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs KJFI Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, KJFI has a market cap of 278.9K. Regarding current trading prices, RVLWF is priced at $0.04, while KJFI trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas KJFI's P/E ratio is -0.06. In terms of profitability, RVLWF's ROE is +3.95%, compared to KJFI's ROE of +0.00%. Regarding short-term risk, RVLWF and KJFI have similar daily volatility (0.00).
RVLWF vs DPAT Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, DPAT has a market cap of 276.9K. Regarding current trading prices, RVLWF is priced at $0.04, while DPAT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas DPAT's P/E ratio is -1.15. In terms of profitability, RVLWF's ROE is +3.95%, compared to DPAT's ROE of +0.45%. Regarding short-term risk, RVLWF is less volatile compared to DPAT. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs HSMD Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, HSMD has a market cap of 153.4K. Regarding current trading prices, RVLWF is priced at $0.04, while HSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas HSMD's P/E ratio is -0.05. In terms of profitability, RVLWF's ROE is +3.95%, compared to HSMD's ROE of -0.04%. Regarding short-term risk, RVLWF and HSMD have similar daily volatility (0.00).
RVLWF vs BNYN Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, BNYN has a market cap of 150.5K. Regarding current trading prices, RVLWF is priced at $0.04, while BNYN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas BNYN's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to BNYN's ROE of -14.10%. Regarding short-term risk, RVLWF is less volatile compared to BNYN. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs COLRF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, COLRF has a market cap of 129.5K. Regarding current trading prices, RVLWF is priced at $0.04, while COLRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas COLRF's P/E ratio is -0.01. In terms of profitability, RVLWF's ROE is +3.95%, compared to COLRF's ROE of +0.02%. Regarding short-term risk, RVLWF and COLRF have similar daily volatility (0.00).
RVLWF vs TPIA Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, TPIA has a market cap of 113.8K. Regarding current trading prices, RVLWF is priced at $0.04, while TPIA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas TPIA's P/E ratio is -0.15. In terms of profitability, RVLWF's ROE is +3.95%, compared to TPIA's ROE of +0.61%. Regarding short-term risk, RVLWF is less volatile compared to TPIA. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs AMBD Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, AMBD has a market cap of 85.6K. Regarding current trading prices, RVLWF is priced at $0.04, while AMBD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas AMBD's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to AMBD's ROE of +1.11%. Regarding short-term risk, RVLWF is less volatile compared to AMBD. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs GENN Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, GENN has a market cap of 49K. Regarding current trading prices, RVLWF is priced at $0.04, while GENN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas GENN's P/E ratio is -0.03. In terms of profitability, RVLWF's ROE is +3.95%, compared to GENN's ROE of +0.00%. Regarding short-term risk, RVLWF and GENN have similar daily volatility (0.00).
RVLWF vs NMHLY Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, NMHLY has a market cap of 41.7K. Regarding current trading prices, RVLWF is priced at $0.04, while NMHLY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas NMHLY's P/E ratio is 0.02. In terms of profitability, RVLWF's ROE is +3.95%, compared to NMHLY's ROE of N/A. Regarding short-term risk, RVLWF and NMHLY have similar daily volatility (0.00).
RVLWF vs DRWN Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, DRWN has a market cap of 24K. Regarding current trading prices, RVLWF is priced at $0.04, while DRWN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas DRWN's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to DRWN's ROE of -0.01%. Regarding short-term risk, RVLWF is less volatile compared to DRWN. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs SCAL Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, SCAL has a market cap of 17.4K. Regarding current trading prices, RVLWF is priced at $0.04, while SCAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas SCAL's P/E ratio is 0.04. In terms of profitability, RVLWF's ROE is +3.95%, compared to SCAL's ROE of +0.07%. Regarding short-term risk, RVLWF and SCAL have similar daily volatility (0.00).
RVLWF vs NAFS Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, NAFS has a market cap of 14K. Regarding current trading prices, RVLWF is priced at $0.04, while NAFS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas NAFS's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to NAFS's ROE of +1.02%. Regarding short-term risk, RVLWF and NAFS have similar daily volatility (0.00).
RVLWF vs CHCR Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, CHCR has a market cap of 12K. Regarding current trading prices, RVLWF is priced at $0.04, while CHCR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas CHCR's P/E ratio is -0.00. In terms of profitability, RVLWF's ROE is +3.95%, compared to CHCR's ROE of N/A. Regarding short-term risk, RVLWF and CHCR have similar daily volatility (0.00).
RVLWF vs ACGI Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, ACGI has a market cap of 10.5K. Regarding current trading prices, RVLWF is priced at $0.04, while ACGI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas ACGI's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to ACGI's ROE of +1.11%. Regarding short-term risk, RVLWF is less volatile compared to ACGI. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs CEVE Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, CEVE has a market cap of 7.7K. Regarding current trading prices, RVLWF is priced at $0.04, while CEVE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas CEVE's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to CEVE's ROE of +2.26%. Regarding short-term risk, RVLWF and CEVE have similar daily volatility (0.00).
RVLWF vs PRMD Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, PRMD has a market cap of 5.6K. Regarding current trading prices, RVLWF is priced at $0.04, while PRMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas PRMD's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to PRMD's ROE of +0.73%. Regarding short-term risk, RVLWF is less volatile compared to PRMD. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs CLRD Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, CLRD has a market cap of 5.4K. Regarding current trading prices, RVLWF is priced at $0.04, while CLRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas CLRD's P/E ratio is -0.01. In terms of profitability, RVLWF's ROE is +3.95%, compared to CLRD's ROE of +0.38%. Regarding short-term risk, RVLWF and CLRD have similar daily volatility (0.00).
RVLWF vs MSGP Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, MSGP has a market cap of 5.2K. Regarding current trading prices, RVLWF is priced at $0.04, while MSGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas MSGP's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to MSGP's ROE of +0.27%. Regarding short-term risk, RVLWF and MSGP have similar daily volatility (0.00).
RVLWF vs MSITF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, MSITF has a market cap of 4.8K. Regarding current trading prices, RVLWF is priced at $0.04, while MSITF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas MSITF's P/E ratio is -0.00. In terms of profitability, RVLWF's ROE is +3.95%, compared to MSITF's ROE of N/A. Regarding short-term risk, RVLWF and MSITF have similar daily volatility (0.00).
RVLWF vs ERUC Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, ERUC has a market cap of 3.9K. Regarding current trading prices, RVLWF is priced at $0.04, while ERUC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas ERUC's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to ERUC's ROE of N/A. Regarding short-term risk, RVLWF is less volatile compared to ERUC. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs SLHPF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, SLHPF has a market cap of 3.9K. Regarding current trading prices, RVLWF is priced at $0.04, while SLHPF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas SLHPF's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to SLHPF's ROE of +0.00%. Regarding short-term risk, RVLWF is less volatile compared to SLHPF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs WEQL Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, WEQL has a market cap of 3.5K. Regarding current trading prices, RVLWF is priced at $0.04, while WEQL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas WEQL's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to WEQL's ROE of +0.21%. Regarding short-term risk, RVLWF and WEQL have similar daily volatility (0.00).
RVLWF vs BBAL Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, BBAL has a market cap of 3.4K. Regarding current trading prices, RVLWF is priced at $0.04, while BBAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas BBAL's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to BBAL's ROE of +0.45%. Regarding short-term risk, RVLWF and BBAL have similar daily volatility (0.00).
RVLWF vs PAOG Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, PAOG has a market cap of 2.5K. Regarding current trading prices, RVLWF is priced at $0.04, while PAOG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas PAOG's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to PAOG's ROE of +0.08%. Regarding short-term risk, RVLWF is less volatile compared to PAOG. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs NMMCF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, NMMCF has a market cap of 2.1K. Regarding current trading prices, RVLWF is priced at $0.04, while NMMCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas NMMCF's P/E ratio is 0.00. In terms of profitability, RVLWF's ROE is +3.95%, compared to NMMCF's ROE of +0.00%. Regarding short-term risk, RVLWF is less volatile compared to NMMCF. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs PPRG Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, PPRG has a market cap of 1.6K. Regarding current trading prices, RVLWF is priced at $0.04, while PPRG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas PPRG's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to PPRG's ROE of -0.58%. Regarding short-term risk, RVLWF and PPRG have similar daily volatility (0.00).
RVLWF vs OHAQ Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, OHAQ has a market cap of 1.4K. Regarding current trading prices, RVLWF is priced at $0.04, while OHAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas OHAQ's P/E ratio is 0.01. In terms of profitability, RVLWF's ROE is +3.95%, compared to OHAQ's ROE of +0.09%. Regarding short-term risk, RVLWF and OHAQ have similar daily volatility (0.00).
RVLWF vs BNKL Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, BNKL has a market cap of 1.2K. Regarding current trading prices, RVLWF is priced at $0.04, while BNKL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas BNKL's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to BNKL's ROE of -7.69%. Regarding short-term risk, RVLWF and BNKL have similar daily volatility (0.00).
RVLWF vs MAHN Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, MAHN has a market cap of 1.2K. Regarding current trading prices, RVLWF is priced at $0.04, while MAHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas MAHN's P/E ratio is 0.05. In terms of profitability, RVLWF's ROE is +3.95%, compared to MAHN's ROE of N/A. Regarding short-term risk, RVLWF is less volatile compared to MAHN. This indicates potentially lower risk in terms of short-term price fluctuations for RVLWF.
RVLWF vs SLHGF Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, SLHGF has a market cap of 398. Regarding current trading prices, RVLWF is priced at $0.04, while SLHGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas SLHGF's P/E ratio is -0.00. In terms of profitability, RVLWF's ROE is +3.95%, compared to SLHGF's ROE of +0.00%. Regarding short-term risk, RVLWF and SLHGF have similar daily volatility (0.00).
RVLWF vs LHRP Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, LHRP has a market cap of 343. Regarding current trading prices, RVLWF is priced at $0.04, while LHRP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas LHRP's P/E ratio is 0.00. In terms of profitability, RVLWF's ROE is +3.95%, compared to LHRP's ROE of N/A. Regarding short-term risk, RVLWF and LHRP have similar daily volatility (0.00).
RVLWF vs NMSCA Comparison
RVLWF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVLWF stands at 38.9B. In comparison, NMSCA has a market cap of 275. Regarding current trading prices, RVLWF is priced at $0.04, while NMSCA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVLWF currently has a P/E ratio of -0.30, whereas NMSCA's P/E ratio is N/A. In terms of profitability, RVLWF's ROE is +3.95%, compared to NMSCA's ROE of +0.02%. Regarding short-term risk, RVLWF and NMSCA have similar daily volatility (0.00).